Macroscopic tumor size as an independent prognostic factor for stage II/III gastric cancer patients who underwent D2 gastrectomy followed by adjuvant chemotherapy with S-1

Gastric Cancer

Volumn 14, Issue 3, 2011, Pages 274-278

  Aoyama, Toru ^a   Yoshikawa, Takaki ^a   Watanabe, Takafumi ^a   Hayashi, Tsutomu ^a   Ogata, Takashi ^a   Cho, Haruhiko ^a   Tsuburaya, Akira ^a  

^a KANAGAWA CANCER CENTER   (Japan)

Author keywords

Adjuvant chemotherapy. S 1; Gastric cancer; Prognostic factor

Indexed keywords

GIMERACIL PLUS OTERACIL POTASSIUM PLUS TEGAFUR;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER INVASION; CANCER PATIENT; CANCER STAGING; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; GASTRECTOMY; HUMAN; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; STOMACH CANCER; SURVIVAL TIME; TUMOR VOLUME;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ANTIMETABOLITES, ANTINEOPLASTIC; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; DRUG COMBINATIONS; FEMALE; FOLLOW-UP STUDIES; GASTRECTOMY; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; OXONIC ACID; PROGNOSIS; PROSPECTIVE STUDIES; STOMACH NEOPLASMS; SURVIVAL RATE; TEGAFUR;

EID: 80053926679     PISSN: 14363291     EISSN: 14363305     Source Type: Journal    
DOI: 10.1007/s10120-011-0038-0     Document Type: Article

References (9)

1. Ohtsu A, Yoshida S, Saijo N. Disparities in gastric cancer chemotherapy between the East and West. J Clin Oncol. 2006;24: 2188-96. (Pubitemid 46630691)
2. Shiraishi N, Inomata M, Osawa N, Yasuda K, Adachi Y, Kitano S. Early and late recurrence after gastrectomy for gastric carcinoma. Univariate and multivariate analyses. Cancer. 2000;89:255-61. (Pubitemid 30489871)
3. Adachi Y, Oshiro T, Mori M, Maehara Y, Sugimachi K. Prediction of early and late recurrence after curative resection for gastric carcinoma. Cancer. 1996;77:2445-8. (Pubitemid 26169140)
4. Bozzetti F, Bonfanti G, Morabito A, Bufalino R, Menotti V, Andreola S, et al. A multifactorial approach for the prognosis of patients with carcinoma of the stomach after curative resection. Surg Gynecol Obstet. 1986;162:229-34. (Pubitemid 16043119)
5. Maruyama K. The most important prognostic factors for gastric cancer patients: a study using univariate and multivariate analyses. Scand J Gastroenterol. 1987;22:63-8. (Pubitemid 17112517)
6. Sakuramoto S, Sasako M, Yamaguchi T, Kinoshita T, Fujii M, Nashimoto A, et al. Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. N Engl J Med. 2007;357:1810-20. (Pubitemid 350044801)
7. Japanese Gastric Cancer Association. Japanese Classification of Gastric Carcinoma. 14th Japanese ed. Tokyo: Kanehara-shuppan; 2010. p. 5-17.
8. Kunisaki C, Makino H, Takagawa R, Oshima T, Nagano Y, Kosaka T, et al. Tumor diameter as a prognostic factor in patients with gastric cancer. Ann Surg Oncol. 2008;15:1959-67.
9. Saito H, Osaki T, Murakami D, Sakamoto T, Kanaji S, Oro S, et al. Macroscopic tumor size as a simple prognostic indicator in patients with gastric cancer. Am J Surg. 2006;192:296-300. (Pubitemid 44223379)